1cbc4235-5c14-457e-a0a9-8db0a4b1e043 - samples

ABSTRACT: We set out to determine ctDNA abundance at de novo mCSPC diagnosis and whether ctDNA provides complementary clinically relevant information to a prostate biopsy. We collected and sequenced 77 plasma cell-free DNA samples from 53 newly diagnosed patients with mCSPC. Targeted sequencing was also performed on DNA from 48 diagnostic prostate tissue samples.

PROVIDER: EGAD00001004526 | EGA |

REPOSITORIES: EGA